1 July 2025, the Dental Biomaterials Adverse Reaction Unit became an integrated unit under NIOM (Nordic Institute of Dental Materials). The move marks an important step in developing a unified Nordic professional environment focused on material safety, patient protection, and knowledge dissemination.

‘This gives us a professional boost and new opportunities, both nationally and in the Nordic region,’ says Trine Lise Lundekvam Berge, acting head of the Adverse Reaction Group, and continues:

"We gain access to a larger interdisciplinary competence platform and closer links to laboratories and relevant research environments. This strengthens our work in the field of adverse reactions."

For many years, the group has been responsible for receiving and assessing reports of adverse reactions to dental materials used in Norway. As part of NIOM, the unit will benefit from enhanced collaboration with clinical and regulatory actors, and its expertise will be shared more broadly across the Nordic region.

Professor Per Vult von Steyern, CEO of NIOM, is very excited and happy that the Dental Biomaterials Adverse Reaction Unit is now an integral part of NIOM:

“The organisational change is a natural step, as NIOM and the Adverse Reaction Unit share many common goals and focus areas. By pooling our resources, we are now further strengthening and expanding our multidisciplinary biomaterials environment under a joint leadership, making NIOM a unique organisation of its kind, with significant national, Nordic and international potential”, he says.

This integration further strengthens NIOM’s role as a Nordic competence centre for dental biomaterials and creates new opportunities for collaboration with universities, dental health centres, and dental services across the Nordic region.

“We also hope this marks the beginning of a stronger jointly Nordic effort to monitor and assess dental biomaterials – for the benefit of both clinicians and decision-makers,” says Per Vult von Steyern.